Drug Chatter -- Tracking biopharma stock chatter

Profile for Merrimack Pharmaceuticals, Inc. (MACK)

« Back to company index

MACK Chatter Timeline

Stock Ticker for MACK

Most Active Tweeters for MACK

UserTweets
@90strappin 8
@OGPayDr0 4
@chaffeybreeze 4
@WKRBNews 4
@IRAMarketReport 4

Recent Tweets for MACK

paynej247 @paynej247
RT @odibro: $MACK Appoints Thomas Needham as CBO
July 24th 2017, 8:07am
ProVesting @ProVesting
$MACK: Merrimack Appoints Thomas Needham as Chief Business Officer: https://t.co/7s23j7FxJa
July 24th 2017, 6:07am
Allstocknews @Allstocknews
$MACK Merrimack Appoints Thomas Needham as Chief Business Officer From our Stock News Alerts App
July 24th 2017, 6:07am
VisualStockRSRC @VisualStockRSRC
$MACK - Merrimack Appoints Thomas Needham as Chief Business Officer https://t.co/X9rBRr1aBf
July 24th 2017, 6:07am
odibro @odibro
$MACK Appoints Thomas Needham as CBO
July 24th 2017, 6:07am
TickerReport @TickerReport
Merrimack Pharmaceuticals, Inc. $MACK Receives $8.97 Consensus Price Target from Analysts https://t.co/pAUdyRchhH
July 23rd 2017, 11:07pm
chaffeybreeze @chaffeybreeze
Merrimack Pharmaceuticals, Inc. $MACK Receives Consensus Rating of “Hold” from Analysts https://t.co/m6kj25vfSI
July 23rd 2017, 11:07pm
TickerReport @TickerReport
Merrimack Pharmaceuticals, Inc. $MACK Receives $8.97 Consensus Price Target from Analysts https://t.co/WKpPenp3Os
July 23rd 2017, 11:07pm
emq_news @emq_news
Merrimack Pharmaceuticals, Inc. $MACK Receives $8.97 Consensus Price Target from Analysts https://t.co/mW8ZZi9NNx
July 23rd 2017, 11:07pm
IRAMarketReport @IRAMarketReport
Merrimack Pharmaceuticals, Inc. $MACK Receives Consensus Rating of “Hold” from Analysts https://t.co/Tr8PPksmOE
July 23rd 2017, 11:07pm
dailymailtimes @dailymailtimes
Merrimack Pharmaceuticals, Inc. $MACK Receives $8.97 Average PT from Brokerages https://t.co/QYuCt29TG6
July 23rd 2017, 10:07pm
BruceWayneTrade @BruceWayneTrade
RT @IRAMarketReport: Merrimack Pharmaceuticals, Inc. $MACK Upgraded at Zacks Investment Research https://t.co/YT0raNfRWx
July 22nd 2017, 1:07am
OGPayDr0 @OGPayDr0
RT @90strappin: Listen to 5:36 am prod. Dolan beats by $MACK #np on #SoundCloud https://t.co/Hp5YawIDBe
July 21st 2017, 1:07pm
OGPayDr0 @OGPayDr0
RT @90strappin: Listen to PAYDR0 - Gorgeous freestyle (FREE GUWOP) prod. Dolan Beats by $MACK #np on #SoundCloud https://t.co/2T46FeKt1v
July 21st 2017, 1:07pm
OGPayDr0 @OGPayDr0
RT @90strappin: Listen to I C IST ft. Creed prod. Supa $tatiq by $MACK #np on #SoundCloud https://t.co/vN11F6soFJ
July 21st 2017, 1:07pm
OGPayDr0 @OGPayDr0
RT @90strappin: Listen to #301 (MOSH PIT MELODIES) prod. Dolan Beats by $MACK #np on #SoundCloud https://t.co/4taWoPvWg8
July 21st 2017, 12:07pm
IRAMarketReport @IRAMarketReport
Merrimack Pharmaceuticals, Inc. $MACK Upgraded at Zacks Investment Research https://t.co/YT0raNfRWx
July 21st 2017, 11:07am
chaffeybreeze @chaffeybreeze
Merrimack Pharmaceuticals, Inc. $MACK Upgraded at Zacks Investment Research https://t.co/NVeOC5HZ6x
July 21st 2017, 11:07am
dakotafinancial @dakotafinancial
Merrimack Pharmaceuticals, Inc. $MACK Upgraded at Zacks Investment Research https://t.co/SN1yox5uDo
July 21st 2017, 10:07am
90strappin @90strappin
RT @90strappin: Listen to $HOGUN ?? - Gunna x 2 prod. Murci by $MACK #np on #SoundCloud https://t.co/n5bAG4hkCf
July 21st 2017, 10:07am
90strappin @90strappin
RT @90strappin: Listen to $HO - I Need Her (prod. Supa Statiq) by $MACK #np on #SoundCloud https://t.co/649g4tXAB1
July 21st 2017, 10:07am
IRAMarketReport @IRAMarketReport
Merrimack Pharmaceuticals $MACK Earns Daily Coverage Optimism Rating of 0.11 https://t.co/043vOzb6AJ
July 20th 2017, 3:07pm
chaffeybreeze @chaffeybreeze
Merrimack Pharmaceuticals $MACK Earns Daily Coverage Optimism Rating of 0.11 https://t.co/WhjrpJualD
July 20th 2017, 3:07pm
90strappin @90strappin
Listen to PAYDR0 - Gorgeous freestyle (FREE GUWOP) prod. Dolan Beats by $MACK #np on #SoundCloud https://t.co/2T46FeKt1v
July 20th 2017, 12:07pm
90strappin @90strappin
Listen to $HOGUN ?? - Gunna x 2 prod. Murci by $MACK #np on #SoundCloud https://t.co/n5bAG4hkCf
July 20th 2017, 11:07am
90strappin @90strappin
Listen to #301 (MOSH PIT MELODIES) prod. Dolan Beats by $MACK #np on #SoundCloud https://t.co/4taWoPvWg8
July 20th 2017, 11:07am
90strappin @90strappin
Listen to 5:36 am prod. Dolan beats by $MACK #np on #SoundCloud https://t.co/Hp5YawIDBe
July 20th 2017, 11:07am
90strappin @90strappin
Listen to I C IST ft. Creed prod. Supa $tatiq by $MACK #np on #SoundCloud https://t.co/vN11F6soFJ
July 20th 2017, 11:07am
90strappin @90strappin
Listen to $HO - I Need Her (prod. Supa Statiq) by $MACK #np on #SoundCloud https://t.co/649g4tXAB1
July 20th 2017, 11:07am
dakotafinancial @dakotafinancial
Bank of New York Mellon Corp Purchases 13,664 Shares of Merrimack Pharmaceuticals, Inc. $MACK https://t.co/YwzcZY4dTR
July 20th 2017, 11:07am
tin_bird1 @tin_bird1
$MACK (1.31) liking the chances here ahead of the Aug 9th E/R date.
July 20th 2017, 9:07am
storminvestor @storminvestor
Bank of New York Mellon Corp Purchases 13,664 Shares of Merrimack Pharmaceuticals, Inc. $MACK https://t.co/rTSXAuUCfO
July 20th 2017, 8:07am
SPNewsAnalysis @SPNewsAnalysis
Bank of New York Mellon Corp Purchases 13,664 Shares of Merrimack Pharmaceuticals, Inc. $MACK https://t.co/Wb0LT3girl
July 20th 2017, 8:07am
SleekMoneycom @SleekMoneycom
Merrimack Pharmaceuticals, Inc. $MACK Short Interest Update https://t.co/HCw8aIRpVq
July 20th 2017, 7:07am
GETHIPPEnt @GETHIPPEnt
RT @eggodinero: AYE ITS DR0 DAY ? DIS BLACK ASS NIGGA DONE SEEN ANOTHER YEAR @OGPayDr0 MORE BLESSINGS MY BRUDDA ? $MACK #GenuineVibesOnly #…
July 19th 2017, 2:07pm
SPNewsAnalysis @SPNewsAnalysis
Zacks Investment Research Upgrades Merrimack Pharmaceuticals, Inc. $MACK to “Hold” https://t.co/Y7KmLAF9W8
July 19th 2017, 11:07am
eggodinero @eggodinero
AYE ITS DR0 DAY ? DIS BLACK ASS NIGGA DONE SEEN ANOTHER YEAR @OGPayDr0 MORE BLESSINGS MY BRUDDA ? $MACK… https://t.co/WpUrbs4sHx
July 19th 2017, 11:07am
WKRBNews @WKRBNews
Merrimack Pharmaceuticals, Inc. $MACK Upgraded to “Hold” at Zacks Investment Research https://t.co/CQcPuU18aO
July 19th 2017, 8:07am
WKRBNews @WKRBNews
Merrimack Pharmaceuticals, Inc. $MACK Upgraded to “Hold” at Zacks Investment Research https://t.co/yVPr5jWHpl
July 19th 2017, 8:07am
WatchlistN @WatchlistN
Merrimack Pharmaceuticals, Inc. $MACK Receives Consensus Rating of “Hold” from Analysts https://t.co/EkHeDC9EWN
July 18th 2017, 3:07pm
dailypoliticaln @dailypoliticaln
Merrimack Pharmaceuticals, Inc. $MACK Downgraded to Sell at Zacks Investment Research https://t.co/akioeqrWg7
July 17th 2017, 7:07pm
midetimes @midetimes
Merrimack Pharmaceuticals, Inc. $MACK Downgraded to Sell at Zacks Investment Research https://t.co/0G5iXX7wSd
July 17th 2017, 7:07pm
IRAMarketReport @IRAMarketReport
Merrimack Pharmaceuticals, Inc. $MACK Downgraded to Sell at Zacks Investment Research https://t.co/P6KF64sJOJ
July 17th 2017, 7:07pm
chaffeybreeze @chaffeybreeze
Merrimack Pharmaceuticals, Inc. $MACK Downgraded to Sell at Zacks Investment Research https://t.co/IzR17CK27y
July 17th 2017, 7:07pm
intercooleronli @intercooleronli
Merrimack Pharmaceuticals, Inc. $MACK Upgraded to “Hold” by Zacks Investment Research https://t.co/hyGPxVfDnp
July 17th 2017, 2:07pm
TheMarketsDaily @TheMarketsDaily
Zacks Investment Research Upgrades Merrimack Pharmaceuticals, Inc. $MACK to “Hold” https://t.co/iXVhhaHavf
July 17th 2017, 2:07pm
WatchlistN @WatchlistN
Zacks Investment Research Upgrades Merrimack Pharmaceuticals, Inc. $MACK to “Hold” https://t.co/QfWfhX16Ts
July 17th 2017, 2:07pm
RatingsNetwork @RatingsNetwork
Merrimack Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/mTtRx2Qi9t $MACK #MACK
July 17th 2017, 2:07pm
ARTHURTITO17 @ARTHURTITO17
JAJAJA FIRST THING YOU HAVE TO KNOW NEVER LISTEN ANYTHING ON TWITTER ! $MACK EVERYBODY WAS BUYING ON FRIDAY! JAJA… https://t.co/yCsM94KuZI
July 17th 2017, 10:07am
Slingshot_Invst @Slingshot_Invst
Continuing our series of calls on $MACK in past few weeks we will be discussing MM-121 in NSCLC in an hour. Join: https://t.co/xmJ1crMdkj
July 17th 2017, 9:07am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.